Quipt Home Medical Corp (QIPT) - Net Assets
Based on the latest financial reports, Quipt Home Medical Corp (QIPT) has net assets worth $34.89 Million USD as of December 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($202.55 Million) and total liabilities ($167.66 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check Quipt Home Medical Corp (QIPT) asset resilience to evaluate the company's liquid asset resilience ratio.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $34.89 Million |
| % of Total Assets | 17.22% |
| Annual Growth Rate | 29.48% |
| 5-Year Change | 129.06% |
| 10-Year Change | 47.22% |
| Growth Volatility | 438.44 |
Quipt Home Medical Corp - Net Assets Trend (1999–2025)
This chart illustrates how Quipt Home Medical Corp's net assets have evolved over time, based on quarterly financial data. Also explore Quipt Home Medical Corp balance sheet assets for the complete picture of this company's asset base.
Annual Net Assets for Quipt Home Medical Corp (1999–2025)
The table below shows the annual net assets of Quipt Home Medical Corp from 1999 to 2025. For live valuation and market cap data, see QIPT market cap.
| Year | Net Assets | Change |
|---|---|---|
| 2025-09-30 | $134.28 Million | +25.73% |
| 2024-09-30 | $106.80 Million | -3.88% |
| 2023-09-30 | $111.11 Million | +39.68% |
| 2022-09-30 | $79.55 Million | +35.69% |
| 2021-09-30 | $58.62 Million | +92.07% |
| 2020-09-30 | $30.52 Million | +270.99% |
| 2019-09-30 | $8.23 Million | -44.84% |
| 2018-09-30 | $14.91 Million | -79.22% |
| 2017-09-30 | $71.76 Million | -21.32% |
| 2016-09-30 | $91.21 Million | -30.32% |
| 2015-09-30 | $130.90 Million | +936.00% |
| 2014-09-30 | $12.64 Million | +1012.02% |
| 2013-09-30 | $1.14 Million | +0.53% |
| 2012-09-30 | $1.13 Million | +17.86% |
| 2011-09-30 | $958.93K | -59.78% |
| 2010-09-30 | $2.38 Million | +3521.17% |
| 2009-09-30 | $-69.69K | +95.56% |
| 2008-09-30 | $-1.57 Million | -637.18% |
| 2007-09-30 | $-212.79K | +76.02% |
| 2006-09-30 | $-887.20K | -62.91% |
| 2005-09-30 | $-544.59K | -1406.96% |
| 2004-09-30 | $41.67K | -91.53% |
| 2003-09-30 | $492.06K | +68.62% |
| 2002-09-30 | $291.81K | +298.34% |
| 2001-09-30 | $73.26K | -69.54% |
| 2000-09-30 | $240.53K | +48.02% |
| 1999-09-30 | $162.50K | -- |
Equity Component Analysis
This analysis shows how different components contribute to Quipt Home Medical Corp's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 18117836900.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (September 2025)
| Component | Amount | Percentage |
|---|---|---|
| Other Components | $281.67 Million | 280.56% |
| Total Equity | $100.39 Million | 100.00% |
Quipt Home Medical Corp Competitors by Market Cap
The table below lists competitors of Quipt Home Medical Corp ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Hyloris Developmentsen Sa
BR:HYL
|
$158.77 Million |
|
Woongjin Co Ltd
KO:016880
|
$158.79 Million |
|
Quanterix Corp
NASDAQ:QTRX
|
$158.82 Million |
|
Lindsay Australia Ltd
AU:LAU
|
$158.86 Million |
|
KEYEAST.Co.Ltd
KQ:054780
|
$158.74 Million |
|
Eastern Water Resources Development and Management Public Company Limited
BK:EASTW
|
$158.68 Million |
|
Donga Geologic
KO:028100
|
$158.62 Million |
|
Ilyang Pharm
KO:007570
|
$158.52 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Quipt Home Medical Corp's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 107,191,000 to 100,395,000, a change of -6,796,000 (-6.3%).
- Net loss of 10,701,000 reduced equity.
- Share repurchases of 130,501 reduced equity.
- Other factors increased equity by 4,035,501.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-10.70 Million | -10.66% |
| Share Repurchases | $130.50K | -0.13% |
| Other Changes | $4.04 Million | +4.02% |
| Total Change | $- | -6.34% |
Book Value vs Market Value Analysis
This analysis compares Quipt Home Medical Corp's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 1.57x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has increased from 0.06x to 1.57x over the analyzed period, suggesting growing market confidence.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 1999-09-30 | $64.74 | $3.65 | x |
| 2000-09-30 | $60.57 | $3.65 | x |
| 2001-09-30 | $14.39 | $3.65 | x |
| 2002-09-30 | $36.91 | $3.65 | x |
| 2003-09-30 | $42.33 | $3.65 | x |
| 2004-09-30 | $0.63 | $3.65 | x |
| 2005-09-30 | $-6.81 | $3.65 | x |
| 2006-09-30 | $-12.64 | $3.65 | x |
| 2007-09-30 | $-3.35 | $3.65 | x |
| 2008-09-30 | $-28.56 | $3.65 | x |
| 2009-09-30 | $-1.27 | $3.65 | x |
| 2010-09-30 | $1.11 | $3.65 | x |
| 2011-09-30 | $0.32 | $3.65 | x |
| 2012-09-30 | $0.35 | $3.65 | x |
| 2013-09-30 | $0.33 | $3.65 | x |
| 2014-09-30 | $1.95 | $3.65 | x |
| 2015-09-30 | $15.36 | $3.65 | x |
| 2016-09-30 | $5.14 | $3.65 | x |
| 2017-09-30 | $3.81 | $3.65 | x |
| 2018-09-30 | $0.74 | $3.65 | x |
| 2019-09-30 | $0.83 | $3.65 | x |
| 2020-09-30 | $1.24 | $3.65 | x |
| 2021-09-30 | $1.93 | $3.65 | x |
| 2022-09-30 | $2.14 | $3.65 | x |
| 2023-09-30 | $2.79 | $3.65 | x |
| 2024-09-30 | $2.52 | $3.65 | x |
| 2025-09-30 | $2.32 | $3.65 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Quipt Home Medical Corp utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -10.66%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -4.36%
- • Asset Turnover: 0.80x
- • Equity Multiplier: 3.04x
- Recent ROE (-10.66%) is above the historical average (-101.11%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 1999 | -20.96% | 0.00% | 0.00x | 1.04x | $-50.30K |
| 2000 | -100.30% | -61.76% | 0.46x | 3.56x | $-265.32K |
| 2001 | -458.67% | -17.28% | 2.14x | 12.43x | $-343.33K |
| 2002 | -53.46% | -4.84% | 2.06x | 5.36x | $-185.18K |
| 2003 | -8.44% | -0.99% | 2.27x | 3.78x | $-90.75K |
| 2004 | -1497.59% | -10.44% | 2.47x | 58.16x | $-628.17K |
| 2005 | 0.00% | -15.44% | 3.02x | 0.00x | $-655.54K |
| 2006 | 0.00% | -5.20% | 3.75x | 0.00x | $-203.28K |
| 2007 | 0.00% | 12.15% | 2.97x | 0.00x | $737.11K |
| 2008 | 0.00% | -81.06% | 1.98x | 0.00x | $-1.62 Million |
| 2009 | 0.00% | 80.68% | 5.86x | 0.00x | $1.27 Million |
| 2010 | -66.89% | -4197.33% | 0.01x | 1.28x | $-1.83 Million |
| 2011 | -164.87% | -113.66% | 0.59x | 2.45x | $-1.68 Million |
| 2012 | -48.49% | -13.83% | 1.53x | 2.29x | $-661.02K |
| 2013 | -224.10% | -66.07% | 0.45x | 7.52x | $-2.66 Million |
| 2014 | -11.10% | -7.38% | 0.52x | 2.88x | $-2.67 Million |
| 2015 | -10.39% | -34.31% | 0.34x | 0.90x | $-35.97 Million |
| 2016 | -62.90% | -59.56% | 0.86x | 1.22x | $-66.49 Million |
| 2017 | -26.69% | -31.11% | 0.60x | 1.43x | $-26.33 Million |
| 2018 | 97.29% | 26.59% | 1.44x | 2.55x | $13.02 Million |
| 2019 | -32.35% | -9.12% | 1.47x | 2.42x | $-7.30 Million |
| 2020 | -16.19% | -6.25% | 1.02x | 2.55x | $-7.40 Million |
| 2021 | -10.53% | -6.03% | 0.94x | 1.85x | $-12.04 Million |
| 2022 | 6.08% | 3.46% | 1.06x | 1.66x | $-3.12 Million |
| 2023 | -2.51% | -1.32% | 0.86x | 2.23x | $-13.90 Million |
| 2024 | -6.31% | -2.75% | 1.00x | 2.30x | $-17.48 Million |
| 2025 | -10.66% | -4.36% | 0.80x | 3.04x | $-20.74 Million |
Industry Comparison
This section compares Quipt Home Medical Corp's net assets metrics with peer companies in the Medical Distribution industry.
Industry Context
- Industry: Medical Distribution
- Average net assets among peers: $1,073,291,921
- Average return on equity (ROE) among peers: -23.04%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Quipt Home Medical Corp (QIPT) | $34.89 Million | -20.96% | 4.81x | $158.74 Million |
| Accendra Health Inc (ACH) | $565.23 Million | -64.17% | 7.24x | $147.73 Million |
| Akso Health Group ADR (AHG) | $17.27 Million | -201.64% | 0.83x | $807.33 Million |
| Cardinal Health Inc (CAH) | $54.00 Million | 12.22% | 2.53x | $45.94 Billion |
| Cencora Inc. (COR) | $75.30 Million | 67.07% | 19.61x | $59.14 Billion |
| Cosmos Health Inc. (COSM) | $-53.68K | 0.00% | 0.00x | $10.83 Million |
| EDAP TMS SA (EDAP) | $19.41 Million | -151.12% | 3.07x | $126.31 Million |
| Empro Group Inc. Ordinary shares (EMPG) | $1.41 Million | 82.70% | 1.73x | $143.05 Million |
| Henry Schein Inc (HSIC) | $3.66 Billion | 0.00% | 1.14x | $8.70 Billion |
| McKesson Corporation (MCK) | $6.27 Billion | 15.35% | 2.82x | $99.71 Billion |
| Owens & Minor Inc (OMI) | $70.80 Million | 9.18% | 1.18x | $185.63 Million |
About Quipt Home Medical Corp
Quipt Home Medical Corp., through its subsidiaries, engages in the provision of durable and home medical equipment and supplies in the United States. The company offers nebulizers; invasive ventilation; and sleep apnea and pap treatment, home ventilation, equipment solutions, daily and ambulatory aids, power mobility, respiratory equipment rental, oxygen therapy services. It also provides solutio… Read more